ATRI — Atrion Income Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMid CapNeutral
- $556.37m
- $556.38m
- $183.51m
- 87
- 45
- 34
- 57
Annual income statement for Atrion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 152 | 155 | 148 | 165 | 184 |
| Cost of Revenue | |||||
| Gross Profit | 71.8 | 70.7 | 66.2 | 69.4 | 75.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 111 | 115 | 112 | 129 | 144 |
| Operating Profit | 41.7 | 40.5 | 35.7 | 36 | 39.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 42 | 43.2 | 38.5 | 38.4 | 40.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 34.3 | 36.7 | 32.1 | 33.1 | 35 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 34.3 | 36.8 | 32.1 | 33.1 | 35 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 34.3 | 36.8 | 32.1 | 33.1 | 35 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 18.4 | 19.7 | 17.4 | 18.2 | 19.6 |
| Dividends per Share |